vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与VINCE HOLDING CORP.（VNCE）财务数据对比。点击上方公司名可切换其他公司
VINCE HOLDING CORP.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$85.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 6.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-5.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Vince是创立于2002年的现代时装品牌，主打简约高级的日常服饰，深受都市消费者喜爱。2023年，Authentic Brands Group以7650万美元收购了该品牌的知识产权。
PBYI vs VNCE — 直观对比
营收规模更大
VNCE
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出21.5%
6.2%
自由现金流更多
PBYI
多$20.1M
$-5.7M
两年增速更快
PBYI
近两年复合增速
6.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $85.1M |
| 净利润 | — | $2.7M |
| 毛利率 | 69.3% | 49.2% |
| 营业利润率 | 22.7% | 6.4% |
| 净利率 | — | 3.2% |
| 营收同比 | 27.7% | 6.2% |
| 净利润同比 | — | -37.3% |
| 每股收益（稀释后） | $0.26 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIVNCE
| Q4 25 | $75.5M | $85.1M | ||
| Q3 25 | $54.5M | $73.2M | ||
| Q2 25 | $52.4M | $57.9M | ||
| Q1 25 | $46.0M | $80.0M | ||
| Q4 24 | $59.1M | $80.2M | ||
| Q3 24 | $80.5M | $74.2M | ||
| Q2 24 | $47.1M | $59.2M | ||
| Q1 24 | $43.8M | $75.3M |
净利润PBYIVNCE
| Q4 25 | — | $2.7M | ||
| Q3 25 | $8.8M | $12.1M | ||
| Q2 25 | $5.9M | $-4.8M | ||
| Q1 25 | $3.0M | $-28.3M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $20.3M | $569.0K | ||
| Q2 24 | $-4.5M | $4.4M | ||
| Q1 24 | $-4.8M | $-4.7M |
毛利率PBYIVNCE
| Q4 25 | 69.3% | 49.2% | ||
| Q3 25 | 77.7% | 50.4% | ||
| Q2 25 | 76.5% | 50.3% | ||
| Q1 25 | 77.1% | 50.1% | ||
| Q4 24 | 76.4% | 50.0% | ||
| Q3 24 | 63.9% | 47.4% | ||
| Q2 24 | 77.4% | 50.6% | ||
| Q1 24 | 75.5% | 45.4% |
营业利润率PBYIVNCE
| Q4 25 | 22.7% | 6.4% | ||
| Q3 25 | 17.6% | 15.2% | ||
| Q2 25 | 12.7% | -7.7% | ||
| Q1 25 | 8.7% | -37.1% | ||
| Q4 24 | 22.6% | 7.2% | ||
| Q3 24 | 27.4% | 1.5% | ||
| Q2 24 | -4.6% | 9.5% | ||
| Q1 24 | -5.3% | -2.2% |
净利率PBYIVNCE
| Q4 25 | — | 3.2% | ||
| Q3 25 | 16.2% | 16.5% | ||
| Q2 25 | 11.2% | -8.3% | ||
| Q1 25 | 6.5% | -35.5% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | 25.2% | 0.8% | ||
| Q2 24 | -9.6% | 7.4% | ||
| Q1 24 | -11.0% | -6.2% |
每股收益（稀释后）PBYIVNCE
| Q4 25 | $0.26 | $0.21 | ||
| Q3 25 | $0.17 | $0.93 | ||
| Q2 25 | $0.12 | $-0.37 | ||
| Q1 25 | $0.06 | $-2.25 | ||
| Q4 24 | $0.40 | $0.34 | ||
| Q3 24 | $0.41 | $0.05 | ||
| Q2 24 | $-0.09 | $0.35 | ||
| Q1 24 | $-0.10 | $-0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $1.1M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $53.4M |
| 总资产 | $216.3M | $246.0M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIVNCE
| Q4 25 | $97.5M | $1.1M | ||
| Q3 25 | $94.4M | $777.0K | ||
| Q2 25 | $96.0M | $2.6M | ||
| Q1 25 | $93.2M | $607.0K | ||
| Q4 24 | $101.0M | $892.0K | ||
| Q3 24 | $96.7M | $711.0K | ||
| Q2 24 | $96.8M | $739.0K | ||
| Q1 24 | $107.2M | $357.0K |
总债务PBYIVNCE
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIVNCE
| Q4 25 | $130.3M | $53.4M | ||
| Q3 25 | $115.3M | $49.3M | ||
| Q2 25 | $104.7M | $37.2M | ||
| Q1 25 | $97.1M | $41.8M | ||
| Q4 24 | $92.1M | $57.1M | ||
| Q3 24 | $71.1M | $52.4M | ||
| Q2 24 | $48.5M | $51.7M | ||
| Q1 24 | $51.0M | $47.2M |
总资产PBYIVNCE
| Q4 25 | $216.3M | $246.0M | ||
| Q3 25 | $202.9M | $239.0M | ||
| Q2 25 | $194.9M | $218.0M | ||
| Q1 25 | $196.2M | $222.7M | ||
| Q4 24 | $213.3M | $254.7M | ||
| Q3 24 | $220.7M | $253.6M | ||
| Q2 24 | $205.0M | $223.1M | ||
| Q1 24 | $214.1M | $225.1M |
负债/权益比PBYIVNCE
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-5.1M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-5.7M |
| 自由现金流率自由现金流/营收 | 19.1% | -6.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.7% |
| 现金转化率经营现金流/净利润 | — | -1.86× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $4.3M |
8季度趋势，按日历期对齐
经营现金流PBYIVNCE
| Q4 25 | $14.4M | $-5.1M | ||
| Q3 25 | $9.7M | $4.2M | ||
| Q2 25 | $14.1M | $-11.8M | ||
| Q1 25 | $3.6M | $22.7M | ||
| Q4 24 | $15.6M | $6.4M | ||
| Q3 24 | $11.0M | $-3.2M | ||
| Q2 24 | $1.0M | $-3.9M | ||
| Q1 24 | $11.2M | $14.8M |
自由现金流PBYIVNCE
| Q4 25 | $14.4M | $-5.7M | ||
| Q3 25 | $9.7M | $2.1M | ||
| Q2 25 | $14.1M | $-13.2M | ||
| Q1 25 | $3.6M | $21.2M | ||
| Q4 24 | $15.6M | $5.1M | ||
| Q3 24 | $11.0M | $-3.9M | ||
| Q2 24 | $1.0M | $-4.6M | ||
| Q1 24 | — | $14.2M |
自由现金流率PBYIVNCE
| Q4 25 | 19.1% | -6.7% | ||
| Q3 25 | 17.7% | 2.9% | ||
| Q2 25 | 26.8% | -22.9% | ||
| Q1 25 | 7.7% | 26.5% | ||
| Q4 24 | 26.4% | 6.4% | ||
| Q3 24 | 13.7% | -5.2% | ||
| Q2 24 | 2.1% | -7.8% | ||
| Q1 24 | — | 18.9% |
资本支出强度PBYIVNCE
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.0% | 0.7% |
现金转化率PBYIVNCE
| Q4 25 | — | -1.86× | ||
| Q3 25 | 1.10× | 0.35× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | 0.54× | -5.61× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
